| Dianne M Murphy, CRNA | |
|
263 Farmington Ave, Farmington, CT 06032-1956 | |
| (860) 679-2000 | |
| Not Available |
| Full Name | Dianne M Murphy |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 22 Years |
| Location | 263 Farmington Ave, Farmington, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033132733 | NPI | - | NPPES |
| 004223814 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 002692 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Dempsey Hospital | Farmington, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Anesthesia Associates Llc | 1759281165 | 373 |
News Archive
A new preprint on the bioRxiv* server describes the interactions between the binding spike protein of the SARS-CoV-2 virus with the antibodies. Earlier studies have addressed the similarity in the 3D structures of the spike protein in the two SARS viruses as seen on cryo-EM.
Researchers from Mount Sinai School of Medicine have discovered the therapeutic benefit of fetal stem cells in helping the maternal heart recover after heart attack or other injury.
The Board of Directors of Baxter International Inc. today declared a quarterly dividend of $0.335 per Baxter common share.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
| Entity Name | Integrated Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636397 PECOS PAC ID: 1759281165 Enrollment ID: O20040112000163 |
News Archive
A new preprint on the bioRxiv* server describes the interactions between the binding spike protein of the SARS-CoV-2 virus with the antibodies. Earlier studies have addressed the similarity in the 3D structures of the spike protein in the two SARS viruses as seen on cryo-EM.
Researchers from Mount Sinai School of Medicine have discovered the therapeutic benefit of fetal stem cells in helping the maternal heart recover after heart attack or other injury.
The Board of Directors of Baxter International Inc. today declared a quarterly dividend of $0.335 per Baxter common share.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
| Entity Name | Uconn Health Center Anesthesiology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710937172 PECOS PAC ID: 2466349667 Enrollment ID: O20040302001136 |
News Archive
A new preprint on the bioRxiv* server describes the interactions between the binding spike protein of the SARS-CoV-2 virus with the antibodies. Earlier studies have addressed the similarity in the 3D structures of the spike protein in the two SARS viruses as seen on cryo-EM.
Researchers from Mount Sinai School of Medicine have discovered the therapeutic benefit of fetal stem cells in helping the maternal heart recover after heart attack or other injury.
The Board of Directors of Baxter International Inc. today declared a quarterly dividend of $0.335 per Baxter common share.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
| Entity Name | Resource Anesthesiology Associates Of Ct Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447233176 PECOS PAC ID: 7517991052 Enrollment ID: O20050923000140 |
News Archive
A new preprint on the bioRxiv* server describes the interactions between the binding spike protein of the SARS-CoV-2 virus with the antibodies. Earlier studies have addressed the similarity in the 3D structures of the spike protein in the two SARS viruses as seen on cryo-EM.
Researchers from Mount Sinai School of Medicine have discovered the therapeutic benefit of fetal stem cells in helping the maternal heart recover after heart attack or other injury.
The Board of Directors of Baxter International Inc. today declared a quarterly dividend of $0.335 per Baxter common share.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dianne M Murphy, CRNA 99 East River Drive, 5th Floor, East Hartford, CT 06108-3212 Ph: (860) 282-0833 | Dianne M Murphy, CRNA 263 Farmington Ave, Farmington, CT 06032-1956 Ph: (860) 679-2000 |
News Archive
A new preprint on the bioRxiv* server describes the interactions between the binding spike protein of the SARS-CoV-2 virus with the antibodies. Earlier studies have addressed the similarity in the 3D structures of the spike protein in the two SARS viruses as seen on cryo-EM.
Researchers from Mount Sinai School of Medicine have discovered the therapeutic benefit of fetal stem cells in helping the maternal heart recover after heart attack or other injury.
The Board of Directors of Baxter International Inc. today declared a quarterly dividend of $0.335 per Baxter common share.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
Barry Miller, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06032 Phone: 860-679-2000 | |
Edward L. Lawson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: John Dempsey Hospital, 263 Farmington Avenue, Mc-2015, Farmington, CT 06030 Phone: 860-679-3516 | |
Charlene Ferris, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06032 Phone: 860-679-2000 | |
Alejandro Andres Bautista, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06032 Phone: 860-679-2000 | |
Molly M Mcgrath, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06032 Phone: 860-629-2000 | |
Dr. Ellis Rasmussen, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2000 |